Frigate Ventures »

Taysha Gene Therapies shares owned by Frigate Ventures

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Frigate Ventures from 13F filings

Historical chart of Frigate Ventures investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Frigate Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Frigate Ventures

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.0M 604k 3.27
2025-06-30 $1.9M 804k 2.31

More positions owned by Frigate Ventures

Quantum Computing Equity (QUBT)
Strive Equity
Eightco Holdings Equity
Brera Holdings Equity
Match Group Equity (MTCH)
Lionsgate Studios Corp Equity (LION)
Nvidia Corp Equity (NVDA)
iShares U.S. Real Estate ETF Option Put Option (IYR)
Five9 Equity (FIVN)
Clear Channel Outdoor Holdings Equity (CCO)
Empery Digital Equity (EMPD)
Invesco QQQ Trust Series 1 Option Put Option (QQQ)
FutureCrest Acquisition Corp Equity Unit
AppLovin Corp Option Put Option (APP)
iShares MSCI Canada ETF Option Put Option (EWC)

View all positions for Frigate Ventures

Top funds holding Taysha Gene Therapies

Rtw Investments
RA Capital Management
venBio Select Advisor
Morgan Stanley
BlackRock
FMR
Goldman Sachs Group
Vanguard Group
Siren
Octagon Capital Advisors
Point72 Asset Management
State Street Corporation
Vestal Point Capital
Deerfield Management Company
Polar Capital Holdings

View all funds holding Taysha Gene Therapies